Scholars Central

Conference abstractPublished 14 Jul 2016

Mass Spectrometry Imaging in the diagnosis of difficult Atypical Spitzoid Neoplasms

Authors: Rossitza Lazova

Yale University School of Medicine, USA

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Background: Previously using Mass Spectrometry Imaging (MSI) we discovered proteomic differences between benign Spitz nevus (SN) and Spitzoid malignant melanoma (SMM). Objective: To investigate whether Mass Spectrometry Imaging can help in the diagnosis of difficult Atypical Spitzoid Neoplasms (ASN); to correlate the results with clinical behavior; and to compare to histopathologic diagnosis. Methods: We conducted a retrospective collaborative study involving centers from 11 countries and 10 institutions in the US. One hundred and four ASNs were analyzed by Mass Spectrometry Imaging. We divided the patients into 4 clinical groups with Groups 1 to 4 representing best to worst clinical behavior. We then correlated the clinical outcome with the Mass Spectrometry Imaging and histopathologic diagnosis. Results: Statistical analyses revealed a very strong association between the diagnosis of SMM by Mass Spectrometry Imaging and clinical category when clinical Group 1 was compared to Groups 2, 3 and 4 with a p < 0.0001. We also compared different melanoma prognostic factors: age, gender, location, depth, ulceration status and mitotic rate. Of those only older age and greater depth were strongly associated with clinically aggressive behavior and poorer outcome (p= 0.01). Conclusions: In this study Mass Spectrometry Imaging diagnosis of ASN showed stronger association with clinical outcome than did histopathologic diagnosis. Diagnosis of Spitzoid malignant melanoma by Mass Spectrometry Imaging was statistically strongly associated with aggressive clinical behavior. Mass Spectrometry Imaging analysis using a proteomic signature can provide reliable diagnosis as well as clinically useful and statistically significant risk assessment for Atypical Spitzoid Neoplasms.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Cancer Science & Therapy.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalCancer Science & Therapy
  • SubjectOncology & Cancer
  • BylineArticles whose byline prints “Rossitza Lazova”